GANX: Gain Therapeutics Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Gain Therapeutics Inc (GANX).

OverviewDividends

$57.29M Market Cap.

As of 05/15/2025 5:00 PM ET (MRY) • Disclaimer

GANX Market Cap. (MRY)


GANX Shares Outstanding (MRY)


GANX Assets (MRY)


Total Assets

$12.12M

Total Liabilities

$4.78M

Total Investments

$31.70K

GANX Income (MRY)


Revenue

$0

Net Income

-$20.41M

Operating Expense

$20.35M

GANX Cash Flow (MRY)


CF Operations

-$18.87M

CF Investing

$4.98M

CF Financing

$13.01M

GANX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$12,123,884 (-34.85%)

$18,609,331 (-22.78%)

$24,099,387 (-38.18%)

$38,985,071 (305.91%)

Assets Current

$11,602,478 (-34.74%)

$17,778,868 (-15.71%)

$21,091,296 (-44.09%)

$37,722,044 (319.70%)

Assets Non-Current

$521,406 (-37.22%)

$830,463 (-72.39%)

$3,008,091 (138.17%)

$1,263,027 (104.86%)

Goodwill & Intangible Assets

$134,268 (-30.57%)

$193,375 (-9.62%)

$213,967 (5.61%)

$202,609 (0%)

Shareholders Equity

$7,339,574 (-41.65%)

$12,578,224 (-33.38%)

$18,879,514 (-45.78%)

$34,817,546 (461.39%)

Property Plant & Equipment Net

$323,334 (-44.75%)

$585,177 (-27.25%)

$804,312 (-20.13%)

$1,007,028 (82.20%)

Cash & Equivalents

$10,385,863 (-11.95%)

$11,794,949 (61.32%)

$7,311,611 (-80.17%)

$36,880,673 (391.46%)

Accumulated Other Comprehensive Income

-$247,549 (-200.12%)

$247,241 (593.97%)

$35,627 (139.30%)

-$90,645 (40.64%)

Deferred Revenue

$299,652 (-75.38%)

$1,216,924 (2105.37%)

$55,180 (-79.29%)

$266,504 (11.28%)

Total Investments

$31,695 (-99.37%)

$5,033,725 (-65.99%)

$14,799,260 (47213.72%)

$31,279 (0%)

Investments Current

$0 (0%)

$4,999,704 (-61.02%)

$12,826,954 (0%)

$0 (0%)

Investments Non-Current

$31,695 (-6.84%)

$34,021 (-98.28%)

$1,972,306 (6205.53%)

$31,279 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$946,259 (-28.26%)

$1,318,965 (-18.89%)

$1,626,100 (190.13%)

$560,479 (-41.71%)

Accumulated Retained Earnings (Deficit)

-$81,194,908 (-33.58%)

-$60,783,717 (-57.81%)

-$38,516,197 (-84.06%)

-$20,925,459 (-197.45%)

Tax Assets

$271,079 (11.75%)

$242,577 (133.52%)

$103,877 (-8.55%)

$113,586 (95.78%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$653,015 (-36.44%)

$1,027,398 (-19.37%)

$1,274,257 (-20.78%)

$1,608,484 (27.52%)

Debt Current

$271,090 (-22.21%)

$348,490 (3.34%)

$337,215 (4.41%)

$322,963 (122.15%)

Debt Non-Current

$381,925 (-43.74%)

$678,908 (-27.55%)

$937,042 (-27.11%)

$1,285,521 (15.19%)

Total Liabilities

$4,784,310 (-20.67%)

$6,031,107 (15.54%)

$5,219,873 (25.25%)

$4,167,525 (22.49%)

Liabilities Current

$3,911,321 (-20.98%)

$4,949,959 (19.99%)

$4,125,251 (61.61%)

$2,552,546 (20.70%)

Liabilities Non-Current

$872,989 (-19.25%)

$1,081,148 (-1.23%)

$1,094,622 (-32.22%)

$1,614,979 (25.43%)

GANX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$55,180 (-60.62%)

$140,108 (-15.08%)

$164,994 (471.29%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$9,559,534 (-11.38%)

$10,787,700 (13.08%)

$9,539,863 (39.74%)

$6,826,938 (446.54%)

Research & Development Expense

$10,791,058 (-6.33%)

$11,520,613 (37.52%)

$8,377,290 (16.93%)

$7,164,229 (217.11%)

Operating Expenses

$20,350,592 (-8.78%)

$22,308,313 (24.51%)

$17,917,153 (28.06%)

$13,991,167 (298.80%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$536,815 (577.16%)

$79,275 (-14.74%)

$92,976 (2219.76%)

$4,008 (-25.58%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$20,411,191 (8.34%)

-$22,267,520 (-26.59%)

-$17,590,738 (-26.64%)

-$13,890,606 (-288.26%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$20,411,191 (8.34%)

-$22,267,520 (-26.59%)

-$17,590,738 (-26.64%)

-$13,890,606 (-288.26%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$20,411,191 (8.34%)

-$22,267,520 (-26.59%)

-$17,590,738 (-26.64%)

-$13,890,606 (-288.26%)

Weighted Average Shares

$22,881,415 (75.86%)

$13,011,361 (9.49%)

$11,883,368 (16.90%)

$10,165,404 (279.11%)

Weighted Average Shares Diluted

$22,881,415 (75.86%)

$13,011,361 (9.49%)

$11,883,368 (16.90%)

$10,165,404 (279.11%)

Earning Before Interest & Taxes (EBIT)

-$19,874,376 (10.43%)

-$22,188,245 (-26.81%)

-$17,497,762 (-26.00%)

-$13,886,598 (-288.73%)

Gross Profit

$0 (0%)

$55,180 (-60.62%)

$140,108 (-15.08%)

$164,994 (471.29%)

Operating Income

-$20,350,592 (8.55%)

-$22,253,133 (-25.18%)

-$17,777,045 (-28.58%)

-$13,826,173 (-297.37%)

GANX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$4,977,507 (-51.31%)

$10,222,667 (169.19%)

-$14,774,813 (-15582.52%)

-$94,212 (-352.38%)

Net Cash Flow from Financing

$13,012,076 (2.93%)

$12,641,343 (16147.61%)

-$78,774 (-100.19%)

$41,766,775 (298.27%)

Net Cash Flow from Operations

-$18,873,827 (-0.04%)

-$18,865,873 (-28.41%)

-$14,692,139 (-18.81%)

-$12,365,670 (-281.63%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$1,411,412 (-131.46%)

$4,486,541 (115.17%)

-$29,569,523 (-200.55%)

$29,407,671 (308.97%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$5,000,000 (-51.16%)

$10,238,025 (169.86%)

-$14,655,860 (0%)

$0 (0%)

Capital Expenditure

-$22,493 (-46.46%)

-$15,358 (87.09%)

-$118,953 (-26.26%)

-$94,212 (-352.38%)

Issuance (Repayment) of Debt Securities

-$90,879 (-2.03%)

-$89,067 (-13.07%)

-$78,774 (-258.86%)

-$21,951 (-102.97%)

Issuance (Purchase) of Equity Shares

$13,383,822 (5.13%)

$12,730,410 (0%)

$0 (0%)

$42,642,214 (24091546.33%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$527,168 (-207.94%)

$488,404 (2152.38%)

-$23,797 (-123.61%)

$100,778 (385.35%)

Share Based Compensation

$2,390,159 (-26.66%)

$3,259,026 (113.51%)

$1,526,434 (81.85%)

$839,371 (928.14%)

Depreciation Amortization & Accretion

$84,071 (0.59%)

$83,579 (30.25%)

$64,168 (314.41%)

$15,484 (61.43%)

GANX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-

-40354.30% (-221.42%)

-12555.10% (-49.13%)

-8418.90% (32.04%)

EBITDA Margin

-

-40059.20% (-221.94%)

-12443.00% (-48.01%)

-8407.00% (31.85%)

Return on Average Equity (ROAE)

-222.60% (-15.34%)

-193.00% (-175.32%)

-70.10% (-99.72%)

-35.10% (71.78%)

Return on Average Assets (ROAA)

-135.50% (-9.98%)

-123.20% (-113.52%)

-57.70% (-81.45%)

-31.80% (54.38%)

Return on Sales (ROS)

-

-40210.70% (-221.97%)

-12488.80% (-48.39%)

-8416.40% (31.96%)

Return on Invested Capital (ROIC)

1091.80% (420.83%)

-340.30% (-111.89%)

-160.60% (94.38%)

-2858.90% (-272.59%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-2.43 (-27.13%)

-1.91 (9.74%)

-2.12 (46.64%)

-3.96

Price to Sales Ratio (P/S)

-

769.88 (190.00%)

265.47 (-20.65%)

334.55

Price to Book Ratio (P/B)

7.81 (132.95%)

3.35 (70.10%)

1.97 (6.31%)

1.85

Debt to Equity Ratio (D/E)

0.65 (36.12%)

0.48 (73.55%)

0.28 (130.00%)

0.12 (-78.14%)

Earnings Per Share (EPS)

-0.89 (47.95%)

-1.71 (-15.54%)

-1.48 (-8.03%)

-1.37 (-3.01%)

Sales Per Share (SPS)

0 (0%)

0 (-66.67%)

0.01 (-25.00%)

0.02 (45.45%)

Free Cash Flow Per Share (FCFPS)

-0.83 (43.07%)

-1.45 (-16.45%)

-1.25 (-1.63%)

-1.23 (-0.82%)

Book Value Per Share (BVPS)

0.32 (-66.80%)

0.97 (-39.14%)

1.59 (-53.61%)

3.42 (48.08%)

Tangible Assets Book Value Per Share (TABVPS)

0.52 (-62.97%)

1.42 (-29.60%)

2.01 (-47.31%)

3.81 (6.50%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (0.00%)

-2 (0.00%)

-2 (0.00%)

-2

Enterprise Value Over EBITDA (EV/EBITDA)

-2.33 (-32.03%)

-1.76 (-11.31%)

-1.58 (12.16%)

-1.8

Asset Turnover

0 (0%)

0 (-40.00%)

0.01 (25.00%)

0 (-33.33%)

Current Ratio

2.97 (-17.43%)

3.59 (-29.75%)

5.11 (-65.40%)

14.78 (247.72%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$18,896,320 (-0.08%)

-$18,881,231 (-27.48%)

-$14,811,092 (-18.87%)

-$12,459,882 (-282.08%)

Enterprise Value (EV)

$46,014,038 (18.23%)

$38,918,609 (41.09%)

$27,584,072 (10.42%)

$24,981,318

Earnings Before Tax (EBT)

-$19,874,376 (10.43%)

-$22,188,245 (-26.81%)

-$17,497,762 (-26.00%)

-$13,886,598 (-288.73%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$19,790,305 (10.47%)

-$22,104,666 (-26.79%)

-$17,433,594 (-25.68%)

-$13,871,114 (-289.34%)

Invested Capital

-$1,654,553 (-161.32%)

$2,698,446 (-80.34%)

$13,722,815 (1332.85%)

$957,727 (-23.17%)

Working Capital

$7,691,157 (-40.05%)

$12,828,909 (-24.38%)

$16,966,045 (-51.76%)

$35,169,498 (411.71%)

Tangible Asset Value

$11,989,616 (-34.90%)

$18,415,956 (-22.90%)

$23,885,420 (-38.41%)

$38,782,462 (303.80%)

Market Capitalization

$57,294,147 (35.92%)

$42,152,267 (13.33%)

$37,194,942 (-42.34%)

$64,507,004

Average Equity

$9,168,939 (-20.51%)

$11,535,164 (-54.04%)

$25,096,680 (-36.55%)

$39,553,924 (1275.28%)

Average Assets

$15,065,730 (-16.64%)

$18,072,557 (-40.70%)

$30,478,396 (-30.31%)

$43,735,406 (752.16%)

Invested Capital Average

-$1,820,352 (-127.92%)

$6,519,592 (-40.14%)

$10,892,039 (2142.40%)

$485,732 (4.34%)

Shares

26,525,068 (105.46%)

12,910,342 (8.64%)

11,883,368 (0.03%)

11,879,743 (4.84%)